Edition:
United Kingdom

Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

75.00PLN
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
75.00zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,925
52-wk High
124.00zł
52-wk Low
66.00zł

About

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in... (more)
No analyst recommendations are available for .

Overall

Beta: 0.27
Market Cap(Mil.): zł1,166.27
Shares Outstanding(Mil.): 13.72
Dividend: --
Yield (%): --

Financials

  MABP.WA Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -5.18 -- --
ROI: -1,451.67 7.52 12.69
ROE: -- 7.94 17.13

BRIEF-Mabion Q1 Net Loss Widens To 15.0 Mln Zlotys

* REPORTED ON THURSDAY Q1 NET LOSS OF 15.0 MILLION ZLOTYS VERSUS LOSS OF 14.3 MILLION ZLOTYS YEAR AGO

17 May 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates